The successful use of mycophenolate mofetil in a patient with active birdshot chorio-retinopathy refractory to azathioprine therapy - Case report

Raul N.G. Vianna, Nadia Al-Kharusi, Jean Deschênes

نتاج البحث: المساهمة في مجلةArticleمراجعة النظراء

ملخص

Report on the effect of oral mycophenolate mofetil (MMF) on the treatment of a patient with active birdshot chorioretinopathy (BC) refractory to azathioprine (AZA) therapy. A sixty-two-year-old female patient with BC developed cystoid macular edema (CME) and severe retinal vasculitis in both eyes. AZA (2 mg/kg/day) was then initially prescribed in order to control the inflammatory process. As AZA failed to control the intraocular inflammation after one year, it was replaced by MMF (2 mg/kg/day), which controlled the inflammatory process and improved the patient's visual acuity. In three years under MMF, no recurrence was observed and her vision remained unchanged. In our patient with active BC refractory to AZA, MMF was effective to decrease the intraocular inflammation, as well as to improve the patient's visual acuity.

اللغة الأصليةEnglish
الصفحات (من إلى)957-959
عدد الصفحات3
دوريةArquivos Brasileiros de Oftalmologia
مستوى الصوت67
رقم الإصدار6
المعرِّفات الرقمية للأشياء
حالة النشرPublished - 2004
منشور خارجيًانعم

ASJC Scopus subject areas

  • ???subjectarea.asjc.2700.2731???

بصمة

أدرس بدقة موضوعات البحث “The successful use of mycophenolate mofetil in a patient with active birdshot chorio-retinopathy refractory to azathioprine therapy - Case report'. فهما يشكلان معًا بصمة فريدة.

قم بذكر هذا